{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Calcium-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris Internationalâ€™s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Calcium network depicts the causal mechanisms that regulate calcium signaling in the context of cell proliferation. The network describes increases in calcineurin complex activity as a result of Wnt-mediated calcium signaling and VEGF signaling, which leads to the induction of NFATC1 transcriptional activity and subsequent cell proliferation. \\nReviewed during Jamboree2015"
    },
    "namespace_url": {
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc-human-genes/hgnc-human-genes-20150601.belns",
      "GOBP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20150601.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20150601.belns",
      "GOCC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20170511.belns",
      "MESHPP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20150601.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20150601.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20150601.belns",
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20150601.belns",
      "SCHEM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-legacy-chemicals/selventa-legacy-chemicals-20150601.belns",
      "EGID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/entrez-gene-ids/entrez-gene-ids-20150601.belns",
      "MESHD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20150601.belns",
      "SDIS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-legacy-diseases/selventa-legacy-diseases-20150601.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20150601.belns",
      "MESHC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20170511.belns",
      "GOBPID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process-ids/go-biological-process-ids-20150601.belns",
      "GOCCID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component-ids/go-cellular-component-ids-20150601.belns",
      "MESHCS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cell-structures/mesh-cell-structures-20150601.belns"
    },
    "namespace_pattern": {},
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20150601.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20150601.belanno",
      "Species": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
      "Tissue": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20150601.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "Abundance",
      "concept": {
        "namespace": "CHEBI",
        "name": "calcitriol"
      },
      "id": "26117682e151074c71a3b06cd295d7c6",
      "bel": "a(CHEBI:calcitriol)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "SCHEM",
        "name": "Inositol 1,4,5-trisphosphate"
      },
      "id": "c3e74d5430331d494b6f3f17a4443e5a",
      "bel": "a(SCHEM:\"Inositol 1,4,5-trisphosphate\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "SCHEM",
        "name": "Calcium"
      },
      "id": "7ef86a69594b2c5229123219d90a9d60",
      "bel": "a(SCHEM:Calcium)"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "GOBP",
        "name": "calcium ion import"
      },
      "id": "bb52b2828b973b0c85d834f184e7cd7a",
      "bel": "bp(GOBP:\"calcium ion import\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "GOBP",
        "name": "cell proliferation"
      },
      "id": "14a7545c48b4be2b5e986ded11b09652",
      "bel": "bp(GOBP:\"cell proliferation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "GOBP",
        "name": "store-operated calcium entry"
      },
      "id": "11938e4c6dd762452de6972eb9479aed",
      "bel": "bp(GOBP:\"store-operated calcium entry\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "SCOMP",
        "name": "Calcineurin Complex"
      },
      "id": "bf1e1ca7cb8d51a800924e79524f6998",
      "bel": "complex(SCOMP:\"Calcineurin Complex\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "SCOMP",
        "name": "NADPH Oxidase Complex"
      },
      "id": "35bae2f590a1bab73b60a8f3c26f37a3",
      "bel": "complex(SCOMP:\"NADPH Oxidase Complex\")"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "HGNC",
            "name": "PDGFA"
          },
          "id": "b7c17c8d5a16e77d54a97090d6ca0838",
          "bel": "p(HGNC:PDGFA)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "HGNC",
            "name": "PDGFA"
          },
          "id": "b7c17c8d5a16e77d54a97090d6ca0838",
          "bel": "p(HGNC:PDGFA)"
        }
      ],
      "id": "bb863fc451f7c5bd37cffb78e77f528f",
      "bel": "complex(p(HGNC:PDGFA), p(HGNC:PDGFA))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "ATP8B1"
      },
      "id": "c88b9a3638c13776821e362b3abc1889",
      "bel": "p(HGNC:ATP8B1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "CCND1"
      },
      "id": "af65521e8dc8a9417952f6aebb7725c6",
      "bel": "p(HGNC:CCND1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "CDK4"
      },
      "id": "72b88c249aeb10a8bbc2e43bc3e428f9",
      "bel": "p(HGNC:CDK4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "CHRNA7"
      },
      "id": "9bc1722fb5ef96f07f754ae7740789e2",
      "bel": "p(HGNC:CHRNA7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "FGF2"
      },
      "id": "6581bba569bd510c92947f02d300354e",
      "bel": "p(HGNC:FGF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "FGFR1"
      },
      "id": "67bd47351f52e87fef232b657e9cd1ee",
      "bel": "p(HGNC:FGFR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "FZD2"
      },
      "id": "575d12201cd39f4560649f1ae709c27c",
      "bel": "p(HGNC:FZD2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "ITPR1"
      },
      "id": "db14c687e5fc085a24d108747dc40a49",
      "bel": "p(HGNC:ITPR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "ITPR2"
      },
      "id": "b7edc823d63240bf2fb0c12fc7e90335",
      "bel": "p(HGNC:ITPR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "ITPR3"
      },
      "id": "c0e1649d8856d9931416e08cb95d4d12",
      "bel": "p(HGNC:ITPR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "KDR"
      },
      "id": "dfadabebebc33f282a378ff9219fef94",
      "bel": "p(HGNC:KDR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "MAPK7"
      },
      "id": "3c2766d13647dfb672d96ce719cb25ef",
      "bel": "p(HGNC:MAPK7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "MTOR"
      },
      "id": "a2450afd51fecb876f80e78722f0ba96",
      "bel": "p(HGNC:MTOR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "NFATC1"
      },
      "id": "1ddab16b74864bbe37b2c79bb163d1b3",
      "bel": "p(HGNC:NFATC1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "ORAI1"
      },
      "id": "64122a457a05afba251ce828905b57e1",
      "bel": "p(HGNC:ORAI1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "PDGFA"
      },
      "id": "b7c17c8d5a16e77d54a97090d6ca0838",
      "bel": "p(HGNC:PDGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "RCAN1"
      },
      "id": "6c02db2dac20e9cbc6bfcb9e2d627b00",
      "bel": "p(HGNC:RCAN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "STIM1"
      },
      "id": "a1066a2592807535623997cee17c9d82",
      "bel": "p(HGNC:STIM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "VEGFA"
      },
      "id": "3537912f85b0c685b323cfa4aaff98c1",
      "bel": "p(HGNC:VEGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "HGNC",
        "name": "WNT5A"
      },
      "id": "32857dc107b0950dd4693029e19b39da",
      "bel": "p(HGNC:WNT5A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "SFAM",
        "name": "CAMK2 Family"
      },
      "id": "fcb91fb80220a4a4695d8175bd67f35e",
      "bel": "p(SFAM:\"CAMK2 Family\")"
    },
    {
      "function": "Pathology",
      "concept": {
        "namespace": "SDIS",
        "name": "Chronic Obstructive Pulmonary Disease"
      },
      "id": "c645977408290adb1174cc64af3b4027",
      "bel": "path(SDIS:\"Chronic Obstructive Pulmonary Disease\")"
    }
  ],
  "links": [
    {
      "line": 0,
      "relation": "increases",
      "evidence": "All patients had initial prestudy calcium values less than or equal to 9.5 mg/100 ml, and phosphate values less than or equal to 4.5 mg/100 ml. Data were analyzed using the Normalized Trend Index (NTI). Calcitriol induced a rise in calcium (8.7 to 10.25 mg/100 ml) (p less than 0.001) and a fall in alkaline phosphatase (p less than 0.005), while D3 had no appreciable effect.",
      "citation": {
        "db": "PubMed",
        "db_id": "205382"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "source": 0,
      "target": 2,
      "key": "84f518afac8a490412d3df8deef8f79d"
    },
    {
      "line": 0,
      "relation": "increases",
      "evidence": "1,25-Dihydroxyvitamin D3 dose dependently increases intracellular calcium in human adipocytes",
      "citation": {
        "db": "PubMed",
        "db_id": "15897475"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "Adipocytes": true
        }
      },
      "source": 0,
      "target": 2,
      "key": "6dd921c4abd55e0ec875e83936878fdf"
    },
    {
      "line": 1,
      "relation": "increases",
      "evidence": "Regions of fibroblast hypercellularity induced by EB1089 were strongly positive for expression of the alveolarization-relevant growth factors, PDGF-AA and vascular endothelial growth factor (VEGF).",
      "citation": {
        "db": "PubMed",
        "db_id": "18432454"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Cell": {
          "fibroblast": true
        }
      },
      "source": 0,
      "target": 27,
      "key": "f5d92dc9df6855d9e7df5856bd8c3192"
    },
    {
      "line": 2,
      "relation": "increases",
      "evidence": "Regions of fibroblast hypercellularity induced by EB1089 were strongly positive for expression of the alveolarization-relevant growth factors, PDGF-AA and vascular endothelial growth factor (VEGF).",
      "citation": {
        "db": "PubMed",
        "db_id": "18432454"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Cell": {
          "fibroblast": true
        }
      },
      "source": 0,
      "target": 8,
      "key": "7566f4e82ad5a12640ded9d2f2b4b38f"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "In cells treated with RNAi specifically designed against frizzled-2, intracellular Ca(2+) in both hypoxia/reoxygenation-treated cells and plasmid-treated cells were decreased.",
      "citation": {
        "db": "PubMed",
        "db_id": "22510436"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Tissue": {
          "myoblast": true
        },
        "Cell": {
          "H9c2": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "source": 15,
      "target": 3,
      "key": "295210a346a720e1fc8986d4d5d88384"
    },
    {
      "line": 19,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor BB induced cyclin D1 expression in a time- and nuclear factor of activated T cells (NFAT)-dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase....Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs",
      "citation": {
        "db": "PubMed",
        "db_id": "19933579"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Myocytes, Smooth Muscle": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 22,
      "target": 11,
      "key": "27be9d620d6dd94ecf5425b3960f36cc"
    },
    {
      "line": 20,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor BB induced cyclin D1 expression in a time- and nuclear factor of activated T cells (NFAT)-dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase....Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs",
      "citation": {
        "db": "PubMed",
        "db_id": "19933579"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Myocytes, Smooth Muscle": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 22,
      "target": 10,
      "key": "fb1d253e7a6673fb835e1775f0fa7db3"
    },
    {
      "line": 21,
      "relation": "increases",
      "evidence": "The NFAT-specific Inhibitor, VIVIT, Inhibits VEGF-induced Proliferation of HPVEC. We demonstrated that VIVIT inhibits VEGF-induced NFATc1 nuclear translocation and that this results in inhibition of VEGF-mediated HPVEC proliferation (Fig. 4). HPVEC retrovirally transduced with GFP-VIVIT (an oligonucleotide coding for VIVIT-containing peptide fused to the N terminus of the green fluorescent protein) did not import NFATc1 to the nucleus upon VEGF stimulation (Fig. 4, C and D). HPVEC expressing GFP alone did show VEGF-induced NFATc1 nuclear localization (Fig. 4, A and B), indicating that the inhibition of NFATc1 nuclear import is specific to the VIVIT peptide and that NFATc1 nuclear shuttling was not disrupted by retroviral transduction",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Endothelial Cells": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 22,
      "target": 4,
      "key": "dc881dd9b552e61a701aba57e3f20dde"
    },
    {
      "line": 7,
      "relation": "positiveCorrelation",
      "evidence": "Reduced quadriceps endurance in chronic obstructive pulmonary disease (COPD) is associated with a predominance of type II glycolytic fibres over type I oxidative fibres (fibre shift)........calcineurin expression was higher..... in COPD patients with fibre shift compared to COPD patients without fibre shift.",
      "citation": {
        "db": "PubMed",
        "db_id": "23258787"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "quadriceps": true
        },
        "Cell": {
          "biopsy": true
        }
      },
      "source": 6,
      "target": 30,
      "key": "eb8f180102961135d8bc3c68195b8312"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Endothelial Cells": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 6,
      "target": 22,
      "key": "34670fde5b1e83fbc4f42cea008578ee"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "Cotransfection of Jurkat cells with vGPCR and an NF-AT luciferase reporter plasmid showed that vGPCR activated NF-AT in a dose-dependent fashion, as judged by NF-AT luciferase reporter gene expression. The activation was calcineurin dependent because it was suppressed by cyclosporine A (CSA), a highly specific calcineurin inhibitor. Cotransfected expression constructs for NF-AT1 and NF-AT2 with vGPCR into KS cells showed that only NF-AT1 and NF-AT2 were activated by vGPCR.",
      "citation": {
        "db": "PubMed",
        "db_id": "12719569"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 6,
      "target": 22,
      "key": "39a2fb84c4ff8b1530af9d8f16850592"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Thus, IGF-1 induces calcineurin-mediated signalling and activation of GATA-2, a marker of skeletal muscle hypertrophy, which cooperates with selected NF-ATc isoforms to activate gene expression programs.",
      "citation": {
        "db": "PubMed",
        "db_id": "10448862"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "Muscle, Skeletal": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 6,
      "target": 22,
      "key": "08e3db0074b6451f2d36c29593bc80bb"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "CnA* muscles displayed threefold higher calcineurin activity and enhanced dephosphorylation of the calcineurin targets NFATc1, MEF2A, and MEF2D.",
      "citation": {
        "db": "PubMed",
        "db_id": "11062266"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Tissue": {
          "Muscle, Skeletal": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tscript"
        }
      },
      "source": 6,
      "target": 22,
      "key": "130f35dc2bcee2164def1a7d3dd1ea5e"
    },
    {
      "line": 10,
      "relation": "directlyIncreases",
      "evidence": "GF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.",
      "citation": {
        "db": "PubMed",
        "db_id": "10896947"
      },
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 13,
      "target": 14,
      "key": "b407f754b0a8138f7342e0c8b4b22c13"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in..medial VSM",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary medial vascular smooth muscle cells": true
        }
      },
      "source": 19,
      "target": 30,
      "key": "665275ee689f8f659c89f5f72f9bfe52"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in...intimal..VSM",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary intimal vascular smooth muscle cells": true
        }
      },
      "source": 19,
      "target": 30,
      "key": "39dfd4a12048eb3186dfdecd73627935"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary endothelial cells": true
        }
      },
      "source": 19,
      "target": 30,
      "key": "edff3918e34178f0ef57914cfab90092"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Endothelial Cells": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 19,
      "target": 6,
      "key": "b96faaf01c52956f3f49b3603dda61d6"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "VEGF-stimulated induction of DSCR1 was blocked by anti-VEGF receptor-2 monoclonal antibody (mAb), or the specific calcineurin inhibitors cyclosporin A and FK506.",
      "citation": {
        "db": "PubMed",
        "db_id": "15263820"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "Endothelium, Vascular": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 19,
      "target": 6,
      "key": "dd0e4162cb494560f9253da589e41feb"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "once bound to its receptor, VEGF initiates an intracellular signaling cascade that leads to changes in expression of the gene that promote endothelial cell migration and proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "12793895"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "6221a57734eff1412023334d49e0d9c2"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "The beta3 integrin is necessary for the activation of PI 3-kinase in endothelial cells stimulated by VEGF-A165  PI 3-kinase belongs to the intracellular signals triggered by VEGF-A in bovine endothelial cells, as demonstrated by the phosphorylation of its regulatory protein p85 (Guo et al., 1995). As shown in Figure 5, wortmannin used at nanomolar concentrations specific for PI 3-kinase inhibition (Arcaro and Wymann, 1993), reduced the human endothelial cells migration induced by VEGF-A165. To determine whether beta3 integrin interferes in PI 3-kinase activation occurring after VEGFR-2 stimulation, we evaluated the effect of BV4 (anti-beta3 subunit mAb) on the phosphorylation in tyrosine residues of the p85 subunit and on the catalytic activity of the enzyme. After pre-incubation with BV4 or with anti-VEGFR-2 Ab for 20 min at 4Â°C, cells were stimulated with VEGF-A165. Cell lysates were immunoprecipitated with anti-p85 mAb, and the separated proteins by SDSâ€“PAGE were probed with anti-phosphotyrosine mAb. VEGF-A165 increased the tyrosine phosphorylation of p85, but it failed to phosphorylate the PI 3-kinase subunit when endothelial cells were pre-incubated with anti-beta3 or anti-VEGFR-2 antibodies (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10022831"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Endothelial Cells": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "75091615a3460663aa356fd213ceca73"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Endothelial Cells": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "be557e3c01dd3ca93a488d6b9390d514"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.",
      "citation": {
        "db": "PubMed",
        "db_id": "20921519"
      },
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "a3e593d36aef8eac153b72f28e9dbe1e"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)",
      "citation": {
        "db": "PubMed",
        "db_id": "16835467"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "8eef0de8613cf726867c2937eed24602"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16336962"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "a2e596720cb93b4975cd5ee34aaeeca8"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "d30ddeff85d169b6af5069a4f4017432"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "ba4c92fae4b69323314ede3ce18a01c3"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 27,
      "target": 19,
      "key": "15f4a7f206e55383029e3c97cb15209f"
    },
    {
      "line": 14,
      "relation": "directlyIncreases",
      "evidence": "Changes in Wnt5a and Fzd2 expression in the spinal cord of SOD1(G93A) transgenic mice (ALS), SOD1(G93A) transfected NSC-34 cells, and primary cultures of astrocytes from SOD1(G93A) transgenic mice were detected by immunofluorescent staining, reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting",
      "citation": {
        "db": "PubMed",
        "db_id": ""
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "source": 28,
      "target": 15,
      "key": "04b9d21b82b86b1e61a54e9f788533b9"
    },
    {
      "line": 14,
      "relation": "directlyIncreases",
      "evidence": "Activation of Frizzled-2 by Wnt5a leads to activation of the phosphatidylinositol pathway (11), activation of the cyclic GMP phosphodiesterase PDE6 (13, 16), and inhibition of protein kinase G (PKG)2  (17), which leads to Ca2+ mobilization (17). [Ma, L., and Wang, H. Y. (2006) J. Biol. Chem. 281, 30990-31001]",
      "citation": {
        "db": "PubMed",
        "db_id": "17684012"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "source": 28,
      "target": 15,
      "key": "f9d1fd9408d233ed75a9bb440fcb772d"
    },
    {
      "line": 15,
      "relation": "decreases",
      "evidence": "DPI, added to the cells at the time of maximum FMLP-activated membrane depolarisation, accelerated the rates of both membrane repolarisation and influx of Ca(2+)",
      "citation": {
        "db": "PubMed",
        "db_id": "15163557"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "neutrophil": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "source": 7,
      "target": 3,
      "key": "4760e93cd96191be312cb0e1970b3602"
    },
    {
      "line": 7,
      "relation": "positiveCorrelation",
      "evidence": "Reduced quadriceps endurance in chronic obstructive pulmonary disease (COPD) is associated with a predominance of type II glycolytic fibres over type I oxidative fibres (fibre shift)........calcineurin expression was higher..... in COPD patients with fibre shift compared to COPD patients without fibre shift.",
      "citation": {
        "db": "PubMed",
        "db_id": "23258787"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "quadriceps": true
        },
        "Cell": {
          "biopsy": true
        }
      },
      "source": 30,
      "target": 6,
      "key": "5dd57186732affeeaca7546da8205912"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in..medial VSM",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary medial vascular smooth muscle cells": true
        }
      },
      "source": 30,
      "target": 19,
      "key": "d5a077511783a6e9c81e31825aa45771"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in...intimal..VSM",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary intimal vascular smooth muscle cells": true
        }
      },
      "source": 30,
      "target": 19,
      "key": "0d09a165e898dbbf755d6848bc200231"
    },
    {
      "line": 12,
      "relation": "positiveCorrelation",
      "evidence": "In patients with COPD, KDR/Flk-1 expression was enhanced in endothelial cells",
      "citation": {
        "db": "PubMed",
        "db_id": "15681497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "pulmonary endothelial cells": true
        }
      },
      "source": 30,
      "target": 19,
      "key": "2a218d3c33bc6bec89a5b93258a5dd8f"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "Calcitriol (1,25 (OH)2D3), a major regulator of mineral metabolism, is generated by 25-hydroxyvitamin D 1Î±-hydroxylase in the kidney. Since 25-hydroxyvitamin D 1Î±-hydroxylase expression is enhanced by IRF-1, the present study explored the role of Chk2 for calcitriol formation and mineral metabolism",
      "citation": {
        "db": "PubMed",
        "db_id": "25319519"
      },
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "source": 9,
      "target": 0,
      "key": "0036732d8349ad56f6f76d2de2595995"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "In IMR-90 and WI-38 cells, serum or bFGF-induced increase in DNA synthesis is strongly dependent on [Ca]out in which cells have been incubated",
      "citation": {
        "db": "PubMed",
        "db_id": "8416921"
      },
      "annotations": {
        "Tissue": {
          "fetal lung": true
        },
        "Cell": {
          "WI-38 fibroblast": true
        }
      },
      "source": 2,
      "target": 13,
      "key": "2aef7f8f7dc3b97c88a22d33b443fd14"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "Elevated extracellular calcium increases fibroblast growth factor-2 gene and protein expression levels...Using RT-PCR, we found that elevated levels of extracellular Ca(2+) increase fibroblast growth factor (FGF)-2 gene expression with a peak at 6h....Cementoblasts share phenotypical features with osteoblasts.",
      "citation": {
        "db": "PubMed",
        "db_id": "20542497"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "osteoblast": true
        }
      },
      "source": 2,
      "target": 13,
      "key": "4f0511f545521674b763f163ab08b0ef"
    },
    {
      "line": 23,
      "relation": "increases",
      "evidence": "Evidence for the requirement of extracellular Ca2+ entry for NADPH oxidase activation is supported by a significant decrease of superoxide anion production when extracellular Ca2+ is suppressed or chelated by EGTA [3 , 8 , 9].",
      "citation": {
        "db": "PubMed",
        "db_id": "18519744"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Neutrophils": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "source": 2,
      "target": 7,
      "key": "b67615a6a6caaf7c1e4f0fea0ad09111"
    },
    {
      "line": 24,
      "relation": "increases",
      "evidence": "HA released Ca(2+) activated CaMK2 through L-type calcium channel",
      "citation": {
        "db": "PubMed",
        "db_id": "20162336"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "MC3T3-E1 osteoblast": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 2,
      "target": 29,
      "key": "9c9ebd182b8ce90609805335578dcd2a"
    },
    {
      "line": 24,
      "relation": "increases",
      "evidence": "We show that histamine synthesis stimulation by depolarization with 30 mM K(+) requires extracellular calcium entry, mostly through N-type channels, and subsequent activation of calcium/calmodulin-dependent protein kinase type II. In vitro, this kinase phosphorylated and activated histidine decarboxylase, the histamine-synthesizing enzyme.",
      "citation": {
        "db": "PubMed",
        "db_id": "15465923"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Tissue": {
          "brain": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 2,
      "target": 29,
      "key": "ec392450531bad44dcb997dfaea6ebd7"
    },
    {
      "line": 25,
      "relation": "increases",
      "evidence": "Chemoattractants are thought to be the first mediators generated at sites of bacterial infection. We hypothesized that signaling through G protein-coupled chemoattractant receptors may stimulate cytokine production. To test this hypothesis, a human mast cell line (HMC-1) that normally expresses receptors for complement components C3a and C5a at low levels was stably transfected to express physiologic levels of fMLP receptors. We found that fMLP, but not C3a or C5a, induced macrophage inflammatory protein (MIP)-1ss (CCL4) and monocyte chemoattractant protein-1 (CCL2) mRNA and protein. Although fMLP stimulated both sustained Ca(2+) mobilization and phosphorylation of extracellular signal-regulated kinase (ERK), these responses to C3a or C5a were transient. However, transient expression of C3a receptors in HMC-1 cells rendered the cells responsive to C3a for sustained Ca(2+) mobilization and MIP-1ss production. The fMLP-induced chemokine production was blocked by pertussis toxin, PD98059, and cyclosporin A, which respectively inhibit G(i)alpha activation, mitgen-activated protein kinase kinase-mediated ERK phosphorylation, and calcineurin-mediated activation of NFAT. Furthermore, fMLP, but not C5a, stimulated NFAT activation in HMC-1 cells. These data indicate that chemoattractant receptors induce chemokine production in HMC-1 cells with a selectivity that depends on the level of receptor expression, the length of their signaling time, and the synergistic interaction of multiple signaling pathways, including extracellular signal-regulated kinase phosphorylation, sustained Ca(2+) mobilization and NFAT activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11120854"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "mast cell": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 6,
      "key": "4cce13eb7585fa42456f757dbf46e8f5"
    },
    {
      "line": 25,
      "relation": "increases",
      "evidence": "Calcineurin is probably activated in overloaded muscles via the chronic increases in intracellular calcium that occur under overloaded conditions as a result of a doubling of nerve-mediated muscle fibre activation and load-related increases in insulin-like growth factor (Dunn et al. 2000).",
      "citation": {
        "db": "PubMed",
        "db_id": "12205177"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Tissue": {
          "muscle": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 6,
      "key": "836f5dedbc16ad6dd38ae1bf13f14372"
    },
    {
      "line": 25,
      "relation": "increases",
      "evidence": "FIGURE 5 | The CRAC-channelâ€“calciumâ€“calcineurinâ€“NFAT signalling pathway as a target for therapeutic immune modulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17703229"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "t-cell": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 6,
      "key": "369a37d6bdc2b85c3bb08451f0e3ba5e"
    },
    {
      "relation": "partOf",
      "source": 24,
      "target": 8,
      "key": "0cbb820775bd1d3fdda8bec2b7816b98"
    },
    {
      "line": 34,
      "relation": "increases",
      "evidence": "Nicotine-induced Ca(2+) response was reversibly blocked by the Î±7-nAChR nicotinic antagonists, methyllycaconitine and Î±-bungarotoxin. Small interfering RNA suppression of Î±7-nAChR also substantially blunted the Ca(2+) responses induced by nicotine.",
      "citation": {
        "db": "PubMed",
        "db_id": "24525957"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Cell": {
          "airway smooth muscle cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 12,
      "target": 3,
      "key": "f027e03cc110dd0e35b55da19bab5408"
    },
    {
      "line": 37,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Jurkat T cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tport"
        }
      },
      "source": 18,
      "target": 5,
      "key": "0db7761a0093939d810fb236685e4c73"
    },
    {
      "line": 41,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "T cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tport"
        }
      },
      "source": 16,
      "target": 5,
      "key": "a2619373306d9bf9530386c3df891736"
    },
    {
      "line": 42,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "Jurkat T cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tport"
        }
      },
      "source": 17,
      "target": 5,
      "key": "3167136a1812d13ad079ba1b50ebe179"
    },
    {
      "line": 43,
      "relation": "increases",
      "evidence": "FIGURE 5 | The CRAC-channelâ€“calciumâ€“calcineurinâ€“NFAT signalling pathway as a target for therapeutic immune modulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17703229"
      },
      "annotations": {
        "Cell": {
          "T cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "cat"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tport"
        }
      },
      "source": 26,
      "target": 23,
      "key": "d469eb55121b13cae38b64f8cf81ea39"
    },
    {
      "line": 45,
      "relation": "increases",
      "evidence": "We found that SOCE was upregulated during ASMC proliferation accompanied by a mild increase of STIM1 and a significant increase of Orai1 mRNA expression, whereas the proliferation of ASMCs was partially inhibited by the SOC channel blockers SKF-96365, NiCl(2), and BTP-2. Suppressing the mRNA expression of STIM1 or Orai1 with specific short hairpin RNA resulted in the attenuation of SOCE and ASMC proliferation. Moreover, after knockdown of STIM1 or Orai1, the SOC channel blocker SKF-96365 had no inhibitory effect on the proliferation of ASMCs anymore.",
      "citation": {
        "db": "PubMed",
        "db_id": "21330611"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Cell": {
          "ASMC": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "tport"
        }
      },
      "source": 23,
      "target": 5,
      "key": "e640cb862f56df5c59d449869632085c"
    },
    {
      "line": 47,
      "relation": "increases",
      "evidence": "Inhibition of Akt/mTOR blocks PDGF-induced stromal interacting molecule 1 (STIM1)/Orai1 expression and PASMC proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "22031597"
      },
      "annotations": {
        "Species": {
          "9606": true
        },
        "Cell": {
          "pulmonary aortic smooth muscle cell": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "bel",
          "name": "kin"
        }
      },
      "source": 21,
      "target": 26,
      "key": "087fff6f98b878373ac22be63f56c746"
    }
  ]
}